v3.23.3
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 26, 2021   35,797          
Beginning balance at Dec. 26, 2021 $ (172,458) $ 490 $ 445,126 $ (9,971) [1] $ 183,157 $ (806,472) $ 15,212
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [2] 45,062       44,258   804
Other comprehensive income (loss), net of tax (3,897)     (3,897) [1]      
Dividends on common stock (39,976)   153   (40,129)    
Exercise of stock options (in shares)   55          
Exercise of stock options $ 2,731 $ 1 2,730        
Acquisition of Company common stock (in shares) (982) (982)          
Acquisition of Company common stock $ (95,000)         (95,000)  
Stock-based compensation expense 14,246   14,246        
Issuance of restricted stock (in shares)   279          
Issuance of restricted stock 88   (8,122)     8,210  
Tax effect of restricted stock awards (in shares)   (92)          
Tax effect of restricted stock awards (9,426)   (9,426)        
Distributions to noncontrolling interests (366)           (366)
Other (in shares)   8          
Other 377   (64)     444 (3)
Ending balance (in shares) at Sep. 25, 2022   35,065          
Ending balance at Sep. 25, 2022 (258,619) $ 491 444,643 (13,868) [1] 187,286 (892,818) 15,647
Beginning balance (in shares) at Jun. 26, 2022   35,248          
Beginning balance at Jun. 26, 2022 (233,798) $ 491 442,255 (11,034) [1] 193,934 (875,205) 15,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [2] 8,433       8,331   102
Other comprehensive income (loss), net of tax (2,834)     (2,834) [1]      
Dividends on common stock (14,922)   57   (14,979)    
Exercise of stock options (in shares)   16          
Exercise of stock options $ 823   823        
Acquisition of Company common stock (in shares) (229) (229)          
Acquisition of Company common stock $ (19,529)         (19,529)  
Stock-based compensation expense 5,146   5,146        
Issuance of restricted stock (in shares)   50          
Issuance of restricted stock 89   (1,671)     1,760  
Tax effect of restricted stock awards (in shares)   (22)          
Tax effect of restricted stock awards (1,900)   (1,900)        
Distributions to noncontrolling interests (216)           (216)
Other (in shares)   2          
Other 89   (67)     156  
Ending balance (in shares) at Sep. 25, 2022   35,065          
Ending balance at Sep. 25, 2022 $ (258,619) $ 491 444,643 (13,868) [1] 187,286 (892,818) 15,647
Beginning balance (in shares) at Dec. 25, 2022 34,700 34,736          
Beginning balance at Dec. 25, 2022 $ (270,664) $ 491 449,829 (10,135) [3] 195,856 (922,434) [4] 15,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [5] 56,221       56,005   216
Other comprehensive income (loss), net of tax 2,219     2,219 [3]      
Dividends on common stock (43,641)   88   (43,729)    
Exercise of stock options (in shares)   35          
Exercise of stock options $ 1,817 $ 1 1,816        
Acquisition of Company common stock (in shares) (2,523) (2,523) [4]          
Acquisition of Company common stock $ (212,444)         (212,444) [4]  
Stock-based compensation expense 13,224   13,224        
Issuance of restricted stock (in shares)   234          
Issuance of restricted stock 0   (6,857)     6,857 [4]  
Tax effect of restricted stock awards (in shares)   (75)          
Tax effect of restricted stock awards (6,279)   (6,279)        
Distributions to noncontrolling interests (651)           (651)
Other (in shares)   66          
Other $ 300   (4,122)     4,422 [4]  
Ending balance (in shares) at Sep. 24, 2023 32,500 32,473          
Ending balance at Sep. 24, 2023 $ (459,898) $ 492 447,699 (7,916) [3] 208,132 (1,123,599) [4] 15,294
Beginning balance (in shares) at Jun. 25, 2023   32,394          
Beginning balance at Jun. 25, 2023 (465,479) $ 492 445,964 (7,289) [3] 207,461 (1,127,669) [4] 15,562
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [5] 15,921       15,861   60
Other comprehensive income (loss), net of tax (627)     (627) [3]      
Dividends on common stock (15,156)   34   (15,190)    
Exercise of stock options (in shares)   18          
Exercise of stock options $ 1,134   1,134        
Acquisition of Company common stock (in shares) 0            
Stock-based compensation expense $ 4,726   4,726        
Issuance of restricted stock (in shares)   7          
Issuance of restricted stock 0   (315)     315 [4]  
Tax effect of restricted stock awards (in shares)   (2)          
Tax effect of restricted stock awards (171)   (171)        
Distributions to noncontrolling interests (328)           (328)
Other (in shares)   56          
Other $ 82   (3,673)     3,755 [4]  
Ending balance (in shares) at Sep. 24, 2023 32,500 32,473          
Ending balance at Sep. 24, 2023 $ (459,898) $ 492 $ 447,699 $ (7,916) [3] $ 208,132 $ (1,123,599) [4] $ 15,294
[1] At September 25, 2022, the accumulated other comprehensive loss of $13,868 was comprised of net unrealized foreign currency translation loss of $12,430 and net unrealized loss on the interest rate swap agreements of $1,438.
[2] Net income to the Company for the three and nine months ended September 25, 2022 excludes $31 and $559, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[3] At September 24, 2023, the accumulated other comprehensive loss of $7,916 was comprised of net unrealized foreign currency translation loss of $8,702 and net unrealized gain on the interest rate swap agreements of $786.
[4] Acquisition of Company common stock for the nine months ended September 24, 2023 includes $2,804 of transaction costs directly attributable to share repurchases, including a 1% excise tax incurred under the Inflation Reduction Act of 2022.
[5] Net income to the Company for the three and nine months ended September 24, 2023 excludes $30 and $135, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.